List your tool

Head to head · 2026

Paige vs Triomics

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Paige

Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025

4.1Not listed

Visit Paige (opens Paige in a new tab)

Triomics

AI for oncology workflows, supporting clinical trial matching and cancer care decisions

4.0Not listed

Visit Triomics (opens Triomics in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Paige does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Paige

    4.1 against 4.0

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onPaigeTriomics
Our rating4.1Better4.0
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Paige Alba AI co-pilot for digital pathology tissue-slide analysis
  • Cancer diagnosis, tissue subtyping, and molecular biomarker discovery support
  • Founded in 2017 by researchers from Memorial Sloan Kettering Cancer Center
  • Acquired by Tempus in August 2025, continuing under its own brand
  • Enterprise deployment with dedicated support for hospital and lab pathology teams
  • AI built specifically for oncology rather than general medicine
  • Clinical trial matching against unstructured patient records
  • Structuring of oncology data for downstream decision support
  • Support across the cancer care decision pathway
  • Designed to assist rather than replace clinician judgement
Pros
  • Research pedigree from Memorial Sloan Kettering lends real clinical credibility
  • Tempus backing adds financial resources and precision-medicine data integration
  • Deep oncology pathology specialization outperforms general-purpose medical imaging AI
  • Trial matching addresses a real and higher-priced manual bottleneck
  • Oncology specialisation rather than a general clinical tool
  • Helps surface treatment options patients would otherwise miss
Cons
  • Enterprise-only pricing requires a sales conversation before evaluation
  • Now part of a larger company, a real change from its independent-startup years
  • Narrow pathology focus means it's not a fit for non-oncology diagnostic workflows
  • Clinical deployment requires validation and governance review
  • No published pricing; enterprise health system sales
CompanyPaige, founded 2017

Prices come from each vendor's pricing page, last checked 20260729. Check the vendor before you buy.

FAQ

Questions people ask

Is Paige better than Triomics?

In our reviews Paige scores 4.1 and Triomics scores 4.0. The better pick depends on the job. Paige: Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025. Triomics: AI for oncology workflows, supporting clinical trial matching and cancer care decisions.

Which is cheaper, Paige or Triomics?

Paige: see pricing. Triomics: see pricing.

Do Paige and Triomics have free plans?

Neither lists a free plan.

More comparisons